StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Deutsche Bank Comments on Eli Lilly (LLY)
February 27, 2024 8:49 AM
Deutsche Bank analyst James Shin reiterated a Hold rating and $695.00 price target on Eli Lilly (NYSE: LLY).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Viking Therapeutic (VKTX) PT Raised to $80 at Stifel, '“Best-in-Class” Profile of Injectable VK2735 Stands Firm'
February 27, 2024 12:06 PM
Viking Therapeutic's (VKTX) Obesity Data Seen as 'Impressive'
February 27, 2024 7:55 AM
Novo Nordisk (NVO), Lilly (LLY) Decline Following Positive Data from Viking Therapeutics (VKTX)
February 27, 2024 7:40 AM
Zealand Pharma stock soars 35% on strong trial results for its weight loss treatment
February 26, 2024 3:12 PM
Eli Lilly (LLY) PT Raised to $885 at Jefferies
February 23, 2024 8:00 AM
